Intellectual Property is back to its creators
The initial founders of AXIM Biotechnologies and the inventors of the world’s first patented controlled-release cannabinoids chewing gum have returned their Intellectual Property into their new company – APIRx Pharmaceuticals.
APIRx Portfolio now includes 10 patents, 28 patent applications, over 35 Trademarks and close to 50 products in various developmental stages.
APIRx Pharmaceuticals B.V. is a leading pharmaceutical company dedicated to manufacturing of natural cannabinoid API’s (Active Pharmaceutical Ingredients), which are extracted from cannabis plant material and purified to pharma grade.